secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002636
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q4 rev ~$28.6M (+78% YoY); FY2023 rev ~$89.1M (+82%); guides FY2024 rev $128-135M
--------------------------------------------------------------------------------

- Q4 2023 rev ~$28.6M (+78% YoY) driven by 77 LDD placements and 18,071 LALs sold.
- FY2023 rev ~$89.1M (+82% YoY); 666 LDD installed base; 54,873 LALs sold.
- Cash and investments ~$127.2M as of Dec 31, 2023.
- FY2024 revenue guidance of $128-135M (+44-52% YoY); gross margin 65-67%.
- Expects 2024 operating expenses $125-128M; non-cash expenses $22-25M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017024002636/0000950170-24-002636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017024002636/rxst-20240107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer